Hairy Leukoplakia Workup
- Author: Denis P Lynch, DDS, PhD; Chief Editor: Dirk M Elston, MD more...
In most cases, the diagnosis is established on clinical basis, while a definitive diagnosis requires both an appropriate histopathological appearance and the demonstration of EBV DNA, RNA, or protein within the epithelial cells of the lesion.
Several immunohistochemical and in situ hybridization kits are commercially available for this purpose, whilst tissue biopsy is indicated only if the lesions are unusual in appearance or ulcerated and suggest cancer.
It is important to differentiate hairy leukoplakia from other, more serious, oral lesions that may have a similar clinical appearance. In some cases, biopsy and histologic examination are required to exclude cancer.
The histopathology of hairy leukoplakia is characterized by the following 5 major features:
- Hyperkeratosis of the upper epithelial layer that represents an altered pattern of keratin expression in the squamous epithelial cells: This hyperkeratosis is largely responsible for the characteristic shaggy or "hairy" gross appearance of the lesion. Superficial infections of the hyperkeratinized epithelium with bacteria or Candida may also be seen.
- Parakeratosis of the superficial epithelial layer: This abnormal persistence of cell nuclei in the superficial epithelial layers may represent incomplete squamous differentiation.
- Acanthosis of the stratum spinosum in the epithelial mid layer: This abnormal expansion of cells occurs with foci or layers of ballooning koilocyte-like cells. The nuclei have a homogenous ground-glass appearance and may contain Cowdry type A intranuclear inclusions.
- Minimal or no inflammation in the epithelial and subepithelial tissues
- Histologically normal basal epithelial layer
Although these characteristic histologic features of hairy leukoplakia are highly suggestive of the diagnosis, none is unique to the lesion. Thus, a definitive diagnosis of hairy leukoplakia requires both an appropriate histologic/cytologic appearance and demonstration of EBV DNA, RNA, or protein within the epithelial cells of the lesion.
Schmidt-Westhausen A, Gelderblom HR, Reichart PA. Oral hairy leukoplakia in an HIV-seronegative heart transplant patient. J Oral Pathol Med. 1990 Apr. 19(4):192-4. [Medline].
Sachithanandham J, Kannangai R, Pulimood SA, Desai A, Abraham AM, Abraham OC, et al. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals. Indian J Med Microbiol. 2014 Jul-Sep. 32(3):261-9. [Medline].
Daniels TE, Greenspan D, Greenspan JS, et al. Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion. J Invest Dermatol. 1987 Aug. 89(2):178-82. [Medline].
Gondak RO, Alves DB, Silva LF, Mauad T, Vargas PA. Depletion of Langerhans cells in the tongue from patients with advanced-stage acquired immune deficiency syndrome: relation to opportunistic infections. Histopathology. 2011 Dec 14. [Medline].
Bravo IM, Correnti M, Escalona L, et al. Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal. 2006 Jan 1. 11(1):E33-9. [Medline].
Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, Gonzalez-Ramirez I, Ponce-de-Leon S. The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients: A 12-Year Study in a Referral Center in Mexico. Medicine (Baltimore). 2003 Jan. 82(1):39-50. [Medline].
Gasparin AB, Ferreira FV, Danesi CC, et al. [Prevalence of oral lesions in persons with HIV and associated factors in a southern Brazilian city]. Cad Saude Publica. 2009 Jun. 25(6):1307-15. [Medline].
Guteta S, Feleke Y, Fekade D, Neway M, Diro E. Prevalence of oral and perioral manifestations in HIV positive adults at Tikur Anbessa Teaching Hospital Addis Ababa, Ethiopia. Ethiop Med J. 2008 Oct. 46(4):349-57. [Medline].
Lopez-Pintor R, Hernandez G, de Arriba L, de Andres A. Comparison of oral lesion prevalence in renal transplant patients under immunosuppressive therapy and healthy controls. Oral Dis. 2009 Jul 27. [Medline].
Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients. Oral Dis. 2006 Jul. 12(4):402-7. [Medline].
De Souza YG, Freese UK, Greenspan D, Greenspan JS. Diagnosis of Epstein-Barr virus infection in hairy leukoplakia by using nucleic acid hybridization and noninvasive techniques. J Clin Microbiol. 1990 Dec. 28(12):2775-8. [Medline]. [Full Text].
Schofer H, Ochsendorf FR, Helm EB, Milbradt R. Treatment of oral 'hairy' leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically). Dermatologica. 1987. 174(3):150-1. [Medline].
Resnick L, Herbst JS, Ablashi DV, eet al. Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA. 1988 Jan 15. 259(3):384-8. [Medline].
Goh BT, Lau RK. Treatment of AIDS-associated oral hairy leukoplakia with cryotherapy. Int J STD AIDS. 1994 Jan-Feb. 5(1):60-2. [Medline].
Coulter ID, Heslin KC, Marcus M, et al. Associations of self-reported oral health with physical and mental health in a nationally representative sample of HIV persons receiving medical care. Qual Life Res. 2002 Feb. 11(1):57-70. [Medline].
Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci. 2011. 53(2):203-11. [Medline].